Rare observations of copper uglies: This term, sometimes used in research communities, refers to a potential temporary accelerated aging appearance
A 99% pure, independently verified peptide can still be rendered useless by a single mishandled step after the vial arrives
Stacking cagrilintide with semaglutide The combination of cagrilintide and semaglutide, known as CagriSema in Novo Nordisk clinical trials, represents the most exciting development in peptide weight management research
It supports the repair process on a cellular level, which can be a game-changer for recovery
After decades with no disease-modifying drug, 20242026 finally delivered the first targeted therapies: Novartis ianalumab met both NEPTUNUS-1 & NEPTUNUS-2 Phase 3 endpoints and won FDA Breakthrough Therapy status in Jan 2026, and J&Js nipocalimab was positive in the Phase 2 DAHLIAS trial ( The Lancet )